IGHE and asthma: Notably, the recent advances in the common pathophysiologic processes underpinning asthma and nasal polyposis highlight the therapeutic importance of targeting shared pathogenic cells and molecules, including eosinophils, IgE, type 2 cytokines, and their receptors (Figure 1) [27,28].